Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience

Halloween Sale: Pro Price Slashed — Redeem Now

Etfdb logo
  • ETF
  • BBH
    Pricing Data
    Change: $0.62 (-0.01%)
    Time: 10/25/16
    Previous Close: $106.22
  • Category
  • Health & Biotech Equities
Last Updated:



Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $93.10
  • 52 Week Hi: $128.54
  • AUM: $541.4 M
  • Shares: 5.1 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 64,787
  • 3 Month Avg. Volume: 64,464

Alternative ETFs in the Health & Biotech Equities Category

Sign Up for Pro to Unlock Data Sign Up
Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Largest (AUM)
Most Liquid (Volume)
Top YTD Performer

Analyst Report

This ETF offers targeted exposure to the biotech industry, a corner of the health care sector that is capable of delivering big returns but also exhibiting significant volatility. Given that risk/return profile, accessing biotech through the exchange-traded wrapper has some obvious appeal; it allows investors to spread out exposure, thereby increasing the opportunity of holding a stock that hits it big. Given that targeted objective, this ETF is probably most useful for those seeking tactical exposure to this corner of the market; the underlying holdings are generally found in broad-based equity ETFs, so there should be little appeal to buy-and-holders. BBH used to be structured as a HOLRDS offered by Merrill Lynch, and converted to a true ETF in 2011. It should be noted, however, that this fund still maintains some of the concentration that was characteristic of HOLDS; a few stocks receive significant allocations in the portfolio, and the top ten holdings combine to make up the majority of assets. There are some other biotech ETFs out there that may be interesting opportunities, including IBB, XBI, FBT, and PBE. Those looking for a deep, balanced portfolio will probably prefer to avoid this Market Vectors ETF and utilize a fund such as IBB or XBI instead.

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for BBH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

BBH Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity A- n/a
Expenses A n/a

Knowledge Centers

BBH In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb Category.

BBH Holdings

Filings Data as of: Oct 04, 2016
Sign Up for Pro to Unlock Data Sign Up

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb Category.

Number of Holdings
Category Low
Category High
% Assets in Top 10
Category Low
Category High

Asset Allocation

Asset Percentage
U.S. Stocks 93.57%
International Stocks 1.79%
U.S. Bonds 0.0%
International Bonds 0.0%
Preferred Stock 0.0%
Convertibles 0.0%
Cash 4.57%
Other 0.06%

Sector Breakdown

Sector Percentage
Health Care 95.36%
Financial Services 0.0%
Communication Services 0.0%
Consumer Defensive 0.0%
Real Estate 0.0%
Industrials 0.0%
Consumer Cyclical 0.0%
Basic Materials 0.0%
Energy 0.0%
Technology 0.0%
Utilities 0.0%

Market Cap Breakdown

Market Cap Percentage
Giant 42.66%
Large 26.11%
Medium 24.31%
Small 2.29%
Micro 0.0%

Region Breakdown

Region Percentage
U.S. 93.57%
Europe 1.79%
Middle East 0.0%
Japan 0.0%
Australia 0.0%
Africa 0.0%
Asia (Developed) 0.0%
Latin America 0.0%
Canada 0.0%
Asia (Emerging) 0.0%

Market Tier Breakdown

Region Percentage
Developed 95.36%
Emerging 0.0%

Country Breakdown

Country Percentage
United States 93.57%
Spain 1.79%
Other 4.64%

BBH Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up

Expenses Ratio Analysis

ETF Average
ETF Wtd. Average
Category Average
Expense Ratio
Category Low
Category High

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:

BBH Performance

This section shows how this ETF has performed relative to its peer group ETFdb Category.

1 Week Return
Category Low
Category High
4 Week Return
Category Low
Category High
13 Week Return
Category Low
Category High
26 Week Return
Category Low
Category High
Year to Date Return
Category Low
Category High
1 Year Return
Category Low
Category High
3 Year Return
Category Low
Category High
5 Year Return
Category Low
Category High

Brought to You by Mitre Media


The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of BBH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

BBH Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
P/E Ratio
Category Low
Category High

As of Aug 25 2016

BBH Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
Dividend Date
Annual Dividend Rate
Annual Dividend Yield
Category Low
Category High

As of Aug 25, 2016

BBH Technicals

Sign Up for Pro to Unlock Data Sign Up

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb Category.

5 Day Volatility
Category Low
Category High
20 Day Volatility
Category Low
Category High
50 Day Volatility
Category Low
Category High
200 Day Volatility
Category Low
Category High
Category Low
Category High
Standard Deviation
Category Low
Category High


  • 20 Day MA: $110.41
  • 60 Day MA: $114.21
  • MACD 15 Period: -3.23
  • MACD 100 Period: -5.64
  • Williams % Range 10 Day: 84.97
  • Williams % Range 20 Day: 94.07
  • RSI 10 Day: 29
  • RSI 20 Day: 36
  • RSI 30 Day: 40
  • Ultimate Oscillator: 40

Bollinger Brands

  • Lower Bollinger (10 Day): $105.50
  • Upper Bollinger (10 Day): $108.36
  • Lower Bollinger (20 Day): $102.84
  • Upper Bollinger (20 Day): $118.32
  • Lower Bollinger (30 Day): $103.80
  • Upper Bollinger (30 Day): $121.77

Support & Resistance

  • Support Level 1: $105.15
  • Support Level 2: $104.69
  • Resistance Level 1: $106.24
  • Resistance Level 2: $106.87


  • Stochastic Oscillator %D (1 Day): 25.82
  • Stochastic Oscillator %D (5 Day): 27.92
  • Stochastic Oscillator %K (1 Day): 30.77
  • Stochastic Oscillator %K (5 Day): 35.39

Fact Sheet

Fact sheets are issued by the ETF provider and framed by Information contained within the fact sheet is not guaranteed to be timely or accurate.

2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.